# MAN2A2

## Overview
The MAN2A2 gene encodes the enzyme mannosidase alpha class 2A member 2, a crucial component of the glycosylation pathway within the Golgi apparatus. This enzyme is classified as a glycoside hydrolase and is involved in the maturation of N-glycans, specifically in the hydrolysis of mannose residues from glycoproteins. The activity of mannosidase alpha class 2A member 2 is essential for the conversion of high-mannose-type N-glycans to complex-type structures, which are vital for proper cellular function and organismal development (kroes2007focused; Akama2006Essential). The gene's expression and the enzyme's activity are implicated in various biological processes, including cell-cell interactions and signaling, and are associated with certain pathological conditions, such as glioblastomas and cholangiocarcinoma (Thonsri2020High; kroes2007focused). Understanding the role of MAN2A2 in these processes provides insights into its potential as a therapeutic target in disease contexts.

## Function
The MAN2A2 gene encodes the enzyme alpha-mannosidase II, which plays a critical role in the N-glycan maturation pathway. This enzyme is involved in the hydrolysis of mannose residues from glycoproteins within the Golgi apparatus, a key step in the processing and modification of N-linked oligosaccharides. The proper function of MAN2A2 is essential for normal cellular glycoprotein trafficking and function, as it facilitates the conversion of high-mannose-type N-glycans to complex-type structures (Akama2006Essential).

In healthy human cells, MAN2A2 is involved in the biosynthesis of complex N-glycans, which are crucial for various cellular functions, including cell-cell interactions and signaling (kroes2007focused). The enzyme's activity is necessary for the expression of complex N-glycan structures, which are important for maintaining normal cellular processes and organismal development. The expression of MAN2A2 is typically downregulated in certain pathological conditions, such as glioblastomas, indicating its role in maintaining normal cellular homeostasis (kroes2007focused).

Overall, MAN2A2 is a vital component of the cellular machinery that ensures proper glycoprotein processing, impacting various biological processes and contributing to the overall health and function of the organism.

## Clinical Significance
Alterations in the expression of the MAN2A2 gene have been implicated in the progression of cholangiocarcinoma (CCA), a type of cancer affecting the bile duct epithelial cells. High glucose and reactive oxygen species (ROS) conditions have been shown to upregulate MAN2A2, contributing to CCA progression by promoting cell proliferation and migration. This upregulation is associated with aberrant high mannose-type N-glycan accumulation, which is linked to cancer progression (Thonsri2020High). The study suggests that targeting ROS signaling could be a potential therapeutic approach for CCA (Thonsri2020High).

In myocardial infarction (MI), MAN2A2 is part of a gene signature associated with metabolic and immune-inflammatory dysregulation. This signature, known as the MTSCPPC signature, is involved in pathways related to immune and inflammatory responses, and its expression levels are linked to drug sensitivity in heart-related diseases (Wu2022Identification). The potential therapeutic properties of ovatodiolide, a diterpenoid derivative, have been explored for targeting this signature, indicating a possible role for MAN2A2 in therapeutic interventions for MI (Wu2022Identification).

## Interactions
MAN2A2, or mannosidase alpha class 2A member 2, is involved in the processing of N-linked glycans in the Golgi apparatus. It plays a crucial role in forming multi-enzyme complexes with other glycosylation-related proteins. MAN2A2 interacts with various N-acetylglucosaminyltransferases (MGATs) and nucleotide sugar transporters (NSTs) to facilitate glycan processing. Specifically, MAN2A2 forms a ternary complex with MGAT1 and MGAT2, suggesting its role as a central hub for MGAT interactions (KhoderAgha2019Nacetylglucosaminyltransferases). It can bind to different MGAT sub-complexes, such as MGAT1-MGAT2, MGAT2-MGAT3, and MGAT4B-MGAT1, through either a single binding interface or separate but interdependent interfaces (KhoderAgha2019Nacetylglucosaminyltransferases).

MAN2A2 is also involved in interactions with nucleotide sugar transporters, forming complexes with proteins like SLC35A2 and SLC35A3, which are crucial for glycosylation processes (Wiktor2021Identification). These interactions highlight MAN2A2's role in the efficient synthesis of complex N-glycans and its importance in glycosylation pathways. The protein's interactions are specific, forming sub-complexes that compete for binding, emphasizing its central role in glycan processing within the Golgi membranes (KhoderAgha2019Nacetylglucosaminyltransferases).


## References


[1. (Akama2006Essential) Tomoya O. Akama, Hiroaki Nakagawa, Nyet Kui Wong, Mark Sutton-Smith, Anne Dell, Howard R. Morris, Jun Nakayama, Shin-Ichiro Nishimura, Ashok Pai, Kelley W. Moremen, Jamey D. Marth, and Michiko N. Fukuda. Essential and mutually compensatory roles of α-mannosidase ii and α-mannosidase iix in n -glycan processing in vivo in mice. Proceedings of the National Academy of Sciences, 103(24):8983–8988, June 2006. URL: http://dx.doi.org/10.1073/pnas.0603248103, doi:10.1073/pnas.0603248103. This article has 61 citations.](https://doi.org/10.1073/pnas.0603248103)

[2. (Thonsri2020High) Unchalee Thonsri, Sopit Wongkham, Chaisiri Wongkham, Shinjiro Hino, Mitsuyoshi Nakao, Sittiruk Roytrakul, Tomoaki Koga, and Wunchana Seubwai. High glucose‐ros conditions enhance the progression in cholangiocarcinoma via upregulation of man2a2 and chd8. Cancer Science, 112(1):254–264, November 2020. URL: http://dx.doi.org/10.1111/cas.14719, doi:10.1111/cas.14719. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cas.14719)

[3. (Wiktor2021Identification) Maciej Wiktor, Wojciech Wiertelak, Dorota Maszczak-Seneczko, Piotr Jan Balwierz, Bożena Szulc, and Mariusz Olczak. Identification of novel potential interaction partners of udp-galactose (slc35a2), udp-n-acetylglucosamine (slc35a3) and an orphan (slc35a4) nucleotide sugar transporters. Journal of Proteomics, 249:104321, October 2021. URL: http://dx.doi.org/10.1016/j.jprot.2021.104321, doi:10.1016/j.jprot.2021.104321. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jprot.2021.104321)

[4. (KhoderAgha2019Nacetylglucosaminyltransferases) Fawzi Khoder-Agha, Paulina Sosicka, Maria Escriva Conde, Antti Hassinen, Tuomo Glumoff, Mariusz Olczak, and Sakari Kellokumpu. N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme–multi-transporter assemblies in golgi membranes in vivo. Cellular and Molecular Life Sciences, 76(9):1821–1832, February 2019. URL: http://dx.doi.org/10.1007/s00018-019-03032-5, doi:10.1007/s00018-019-03032-5. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03032-5)

[5. (Wu2022Identification) Alexander T. H. Wu, Bashir Lawal, Yew-Min Tzeng, Chun-Che Shih, and Chun-Ming Shih. Identification of a novel theranostic signature of metabolic and immune-inflammatory dysregulation in myocardial infarction, and the potential therapeutic properties of ovatodiolide, a diterpenoid derivative. International Journal of Molecular Sciences, 23(3):1281, January 2022. URL: http://dx.doi.org/10.3390/ijms23031281, doi:10.3390/ijms23031281. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms23031281)

6. (kroes2007focused) Roger A Kroes, Glyn Dawson, and Joseph R Moskal. Focused microarray analysis of glyco-gene expression in human glioblastomas. Journal of neurochemistry, 103:14–24, 2007. This article has 96 citations and is from a domain leading peer-reviewed journal.